Microport Urocare is a subsidiary of MicroPort Medical Science Co., Ltd. and has been committed to the R&D, production, and sales of interventional medical devices and consumables since its founding in 1998. The company operates in the fields of urology, gynecology, gastroenterology, and respiratory. Its R&D center is located in Shanghai, while its manufacturing base is situated in Jiaxing, Zhejiang Province, covering an extensive area of nearly 3,000 square meters. The company specializes in the development and launch of the single-use ureteroscope and various consumables, such as guidewires, stone retrieval baskets, and access sheaths, offering a comprehensive solution for kidney stone management. This innovative approach underscores their commitment to patient-centric care, as reflected in their slogan, "The Patient Always Comes First." The most recent investment was a Post-IPO Equity investment made on 02 August 2022, with participation from Shenzhen Capital Group and BOPU. With its focus on Biotechnology, Health Care, and Manufacturing, Microport Urocare continues to be a key player in the medical device industry, headquartered in China. For further details, inquiries can be directed to [email protected].
No recent news or press coverage available for Microport Urocare.